Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Small Cell Lung Carcinoma 1Rectal Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphoid 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Ovarian Cancer 1

Interventions

Carboplatin 2Bevacizumab 2stenoparib 1senaparib 1sargramostim 1olaparib 1liposomal doxorubicin 1Saline Solution 1Paclitaxel 1Neoadjuvant Therapy 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Ovarian Cancer × Antineoplastic Agents × Clear all
NCT03611179 2018-08-02

Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer

Assiut University

Phase 2 Unknown
40 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡